P3 Health Partners Inc reports results for the quarter ended June 30 - Earnings Summary

• P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of $6.23​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-4.50. The mean expectation of five analysts for the quarter was for a loss of $4.74 per share. Wall Street expected results to range from $-5.18 to $-4.43 per share.

• Revenue fell 6.2% to $355.79 million from a year ago; analysts expected $358.22 million.

• P3 Health Partners Inc's reported EPS for the quarter was a loss of $6.23​.

• The company reported a quarterly loss of $20.36 million.

• P3 Health Partners Inc shares had risen by 12.7% this quarter and lost 36.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 20.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for P3 Health Partners Inc is $15.00, about 52.7% above its last closing price of $7.10

This summary was machine generated from LSEG data August 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)